Strand Therapeutics
Healthcare & Life Sci
Company overview
Strand Therapeutics is a clinical-stage biotechnology company. It develops mRNA-based treatments for cancers and autoimmune diseases. Its work is built on technology platforms called SignalPath LNPs, SignalLock RNA, and SignalScript RNA. In August 2025, the company raised $153 million in Series B financing. Strand Therapeutics is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States